![U.S. Food and Drug Administration Approves Haegarda (C1 Esterase Inhibitor Subcutaneous [Human]) for Prevention of Hereditary Angioedema (HAE) Attacks in Pediatric Patients](https://alternative-medicine-ny.com/wp-content/uploads/sites/31/2018/11/TQhauKsZaWagomfidiOJ.jpg)
KING OF PRUSSIA, PA – September 28, 2020 – CSL Behring, a global biotherapeutics leader, announced today that the U.S….
Read More
FDA Approves First Over-the-Counter Device To Treat Sinus Pain
Here’s what you need to know about the new device. How does ClearUP work? The ClearUP device is the first…
Read More
FDA Approves Drugs for Treatment of Two Rare Blood Diseases
MONDAY, Dec. 24, 2018 — Two drugs have been approved by the U.S. Food and Drug Administration for the treatment…
Read More
FDA Approves Daurismo
November 21, 2018 — The U.S. Food and Drug Administration today approved Daurismo (glasdegib) tablets to be used in combination…
Read More
FDA Approves Yupelri
November 09, 2018 — Today, the U.S. Food and Drug Administration (FDA) approved Yupelri (revefenacin) Inhalation Solution for the maintenance…
Read More
FDA Approves Lorbrena
November 2, 2018 Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved Lorbrena [lor-BREN-ah]…
Read More